4.8 Letter

Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum

期刊

NEW ENGLAND JOURNAL OF MEDICINE
卷 385, 期 25, 页码 -

出版社

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMc2114706

关键词

-

资金

  1. Japan Agency for Medical Research and Development (AMED) Research Program on Emerging and Re-emerging Infectious Diseases [20fk0108146, 20fk0108413, 20fk0108451]
  2. AMED Research Program on HIV/AIDS [21fk0410039]
  3. Japan Science and Technology (JST) Strategic International Collaborative Research Program (SICORP) e-ASIA [JPMJSC20U1]
  4. JST SICORP [JPMJSC21U5]
  5. JST CREST [JPMJCR20H6, JPMJCR20H4]
  6. Japan Society for the Promotion of Science (JSPS) [18H02662, 21H02737]
  7. JSPS Fund for the Promotion of Joint International Research (Fostering Joint International Research) [18KK0447]
  8. JSPS Core-to-Core Program [JPJSCCA20190008]
  9. JSPS [DC1 19J20488]
  10. Tokyo Biochemical Research Foundation
  11. Grants-in-Aid for Scientific Research [21H02737, 18KK0447] Funding Source: KAKEN

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据